Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 09, 2019

SELL
$30.3 - $41.14 $91,172 - $123,790
-3,009 Closed
0 $0
Q1 2019

Apr 19, 2019

SELL
$29.37 - $40.49 $572,068 - $788,664
-19,478 Reduced 86.62%
3,009 $572,000
Q4 2018

Feb 04, 2019

BUY
$30.16 - $43.0 $109,209 - $155,703
3,621 Added 19.19%
22,487 $756,000
Q3 2018

Nov 14, 2018

BUY
$32.83 - $42.51 $17,531 - $22,700
534 Added 2.91%
18,866 $796,000
Q2 2018

Aug 02, 2018

BUY
$28.77 - $48.27 $41,054 - $68,881
1,427 Added 8.44%
18,332 $587,000
Q1 2018

May 11, 2018

BUY
$49.22 - $68.43 $24,363 - $33,872
495 Added 3.02%
16,905 $841,000
Q4 2017

Feb 05, 2018

BUY
$52.14 - $59.94 $4,640 - $5,334
89 Added 0.55%
16,410 $885,000
Q3 2017

Nov 02, 2017

BUY
$51.16 - $58.21 $834,982 - $950,045
16,321
16,321 $947,000

Others Institutions Holding ANIK

About Anika Therapeutics, Inc.


  • Ticker ANIK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,599,900
  • Market Cap $375M
  • Description
  • Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...
More about ANIK
Track This Portfolio

Track Isthmus Partners, LLC Portfolio

Follow Isthmus Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Isthmus Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Isthmus Partners, LLC with notifications on news.